Health & Pharm General

Digital Promotion Solution For Medical Specialists & Surgeons in Croydon: Multi-Media Marketing

🕔6/10/2024 2:04:31 PM

Although it is vitally important for medical specialists and surgeons to have a constant flow of patients to serve, promoting themselves online has certain challenges.

Read Full Article

Identité Adds LoginFree© to its Award-Winning PasswordFree Authentication®

🕔6/6/2024 3:00:00 PM

Identité®, a company that is committed to eliminating passwords, credential phishing, and account takeover, has released a new capability that eliminates the need for users to type a username to log in.

Read Full Article

Qumulo Enhances Platform with Advanced Conversational AI Powered by Vectara

🕔6/6/2024 12:11:21 PM

Vectara, the Trusted Generative AI Product Platform, and Qumulo, the provider of the only Scale AnywhereTM unstructured data platform, have announced a significant enhancement to the search functionality across Qumulo’s critical web properties, including the Documentation Portal, Qumulo Care, and its main website, www.

Read Full Article

Corin Attains Australian TGA Registration of Apollo™ Robotic-Assisted Surgical Platform

🕔6/5/2024 7:00:00 PM

Corin Group, a leading robotics and AI innovator in orthopaedics, is proud to announce Australian Therapeutic Goods Administration (TGA) registration of its Apollo™ robotic-assisted surgical platform and the ApolloKnee™ software application.

Read Full Article

Dayhouse Studio launches the first design magazine focused on nature, health and sustainability, “Dayhouse Living”

🕔6/5/2024 5:00:00 PM

Dayhouse Studio, a health-focused biophilic interior design firm, today launched a new online magazine where design meets nature, health and sustainability.

Read Full Article

Global Workplace Utilization Jumps 36% in Q1: XY Sense Study

🕔6/5/2024 3:00:00 PM

Working from the office is back. Global workplace utilization grew to its highest level in four years, jumping by 36% over the Q4 2023 level, according to the latest report from XY Sense, the actionable intelligence platform for real estate teams.

Read Full Article

Akaal Pharma has completed recruitment for a Phase-2 clinical trial for atopic dermatitis and associated pruritus

🕔6/5/2024 6:15:54 AM

Akaal Pharma Pty Ltd has completed recruitment for a Phase-2 clinical trial involving patients with atopic dermatitis and associated pruritus. Akaal Pharma Pty Limited (Akaal) today announced that it has completed recruitment of 140 patients for its Phase 2 clinical study to evaluate safety, tolerability and efficacy of topical 1% AKP-119 in atopic dermatitis participants with pruritus.

Read Full Article